The uncomfortable math of research commercialization:
- PubMed adds thousands of biomedical papers a week.
- arXiv adds thousands more.
- The patent corpus grows by hundreds of thousands of filings a year.
- Federal funding programs open and close on their own clock.
And the average tech-transfer office is a handful of people.
Nobody reads it all. So decisions get made on the slice someone had time to read — and the white space, the competing filings, the funding window that closes next month live in the slice nobody got to.
The fix isn't reading faster
It's synthesis: patents, literature, funding, trials, and market context fused into one artifact, with the sources attached so an expert can check any claim in one click.
That's the whole product. One topic in, one decision-ready dashboard out.
